Dutch Heart Foundation

• NCT07234422

  Collaborator, Phase 3, Recruiting, 1,100 people, 18 Nov 2025

• NCT05597202

  Collaborator, Phase 4, Status unknown, 22 people, 27 Oct 2022

• NCT04834388

  Collaborator, Phase 2, Status unknown, 75 people, 8 Apr 2021

• NCT02565693

  Collaborator, Phase 2, Completed, 101 people, 1 Oct 2015

• NCT01204333

  Collaborator, Phase 2/3, Terminated, 67 people, 17 Sept 2010

• Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes

  2021T055, 29 Sept 2026

• Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study

  30 Aug 2026

• Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk

  03-006-2023-0095, 29 Aug 2026

Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov

• Biomarkers in plasma and extracellular vesicles for early detection of asymptomatic ischemic heart disease: a retrospective case-control study

  Grants or research support, 30 Jul 2026

Sources: pubmed.ncbi.nlm.nih.gov